glp-1 obesity drug news today september 2025 New Daily Weight Loss Pill Aims to Take on Ozempic GLP-1 Weight-Loss Drug Demonstration Begins

Benaglutide Benaglutide (HYBR-014) is the world's first human amino acid sequence GLP-1 drug independently developed by BENEMAE

Topical application is not prohibited

Its essential to discuss risk and benefits with your healthcare provider and to be aware of the potential side effect in order to manage them effectively: Nausea and vomiting : These are the most common side effects and usually decrease over time

Always speak with your doctor or licensed medical professional about your individual health or medical needs before starting any new treatment or programme

doi: 10.1016/j.tem.2016.10.001 30 DuringMJCaoLZuzgaDSFrancisJSFitzsimonsHLJiaoXet al

+6.5pp absolute difference First open-label head-to-head between single and dual receptor agonists